Article Details
Retrieved on: 2022-08-05 18:41:49
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... and licence agreement with Roche Holding AG, for the development of allogeneic CAR-T therapies directed towards hematologic malignancies.
Article found on: www.sharesmagazine.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here